The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...
Pregnancy and breastfeeding induces the accumulation of specialized immune cells that reduce the chances of breast cancer ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...
T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...
Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...
A research team has introduced a novel cancer immunotherapy strategy. This approach involves attaching "fake targets" to ...